[Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments]
- PMID: 16767478
- DOI: 10.1007/s00108-006-1626-7
[Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments]
Abstract
The development and clinical introduction of targeted therapies has resulted in significant progress for the treatment of malignant diseases. These forms of therapy supplement traditional methods of chemotherapy, radiation, and surgery. As new therapies increase the complexity of therapeutic options in oncology, the treatment costs steadily climb as well. Parameters need to be identified which will predict a response to new substances, and this effort is the subject of ongoing studies.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
